World-class benchmarking of Guizhou Bailing Group Pharmaceutical

Company: Guizhou Bailing Group Pharmaceutical Company Limited

Bloomberg ticker: 002424 SZ

Market capitalization: $1,163 million

Background: Guizhou Bailing Group Pharmaceutical Company Limited is a Chinese company specializing in the research, production and sales of traditional Chinese and Miao ethnic medicines. It mainly operates in China and is known for its Miao drug products such as Yindan XinnaoTong Softgels.

• Position 6 for profitable growth was the same compared to the 6th position of the previous period
• This is a below-average performance compared to 310 mid-sized healthcare companies worldwide
• The profitability ranking of 8 was worse than the growth ranking of 2
• The profitability ranking of 8 was the same compared to the previous period’s 8th ranking
• This is a below-average performance compared to sector peers
• Growth position 2 was the same compared to the 2nd position of the previous period
• This is world-class performance compared to comparable companies

INDEMNIFICATION: This content is for informational purposes only. It is not intended as investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may contain errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.